Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Regulus Therapeutics (RGLS)

Regulus Therapeutics (RGLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Regulus: Q3 Earnings Snapshot AP - Thu Nov 7, 4:13PM CST

Regulus: Q3 Earnings Snapshot

RGLS : 1.5300 (-3.77%)
Regulus: Q2 Earnings Snapshot AP - Thu Aug 8, 4:19PM CDT

Regulus: Q2 Earnings Snapshot

RGLS : 1.5300 (-3.77%)
Regulus: Q1 Earnings Snapshot AP - Thu May 9, 4:16PM CDT

Regulus: Q1 Earnings Snapshot

RGLS : 1.5300 (-3.77%)
Regulus: Q4 Earnings Snapshot AP - Thu Mar 21, 3:22PM CDT

Regulus: Q4 Earnings Snapshot

RGLS : 1.5300 (-3.77%)
Regulus: Q3 Earnings Snapshot AP - Thu Nov 9, 2023

Regulus: Q3 Earnings Snapshot

RGLS : 1.5300 (-3.77%)
Regulus Therapeutics Advances to Cohort 3 of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) PR Newswire - Thu Oct 19, 2023

/PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines...

RGLS : 1.5300 (-3.77%)
Regulus Therapeutics Announces Positive Topline Data from the First Cohort of Patients in its Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) PR Newswire - Wed Sep 20, 2023

/PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines...

RGLS : 1.5300 (-3.77%)
Regulus Therapeutics Announces Completion of Enrollment in Second Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) PR Newswire - Wed Sep 13, 2023

/PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines...

RGLS : 1.5300 (-3.77%)
Regulus Therapeutics Announces Participation at Two Healthcare Investment Conferences PR Newswire - Tue Sep 5, 2023

/PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines...

RGLS : 1.5300 (-3.77%)
Regulus: Q2 Earnings Snapshot AP - Tue Aug 8, 2023

Regulus: Q2 Earnings Snapshot

RGLS : 1.5300 (-3.77%)

Barchart Exclusives

3 Pharma Stocks to Buy as California Sounds the Alarm on Bird Flu Cases Barchart - Mon Dec 23, 3:37PM CST
The bird flu crisis is creating investment opportunities in the pharmaceutical sector, with Sanofi, GSK, and CSL Limited emerging as top picks. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot